PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | |depression |
| Sentences | 81 |
| PubMedID- 24392265 | Evidence reveals that both psychotherapeutic treatment (eg, cognitive-behavioral therapy) and pharmacologic treatment (eg, use of the selective serotonin reuptake inhibitor sertraline) are safe and effective in reducing depression severity in patients with cardiovascular disease. |
| PubMedID- 23567371 | Background: depression was positively associated with cardiovascular disease (cvd) or mortality in previous studies. |
| PubMedID- 26278479 | In a recent meta-analysis of major depressive disorder (mdd) and hrv, kemp et al.2 reveal that unmedicated depression without cardiovascular disease (cvd) is associated with decreased vagal (parasympathetic) tone, as indexed by reduced hrv. |
| PubMedID- 21731754 | depression often coexists with cardiovascular disease, and nearly 7% of warfarin users are co-prescribed antidepressants [4]. |
| PubMedID- 26078821 | Cox-2 inhibitors cause neuron inflammation that can consequently lead to worsening depression and increase probability of cardiovascular diseases. |
| PubMedID- 22846457 | It is well known that depression influences the development of cardiovascular disease in several ways [1-4]. |
| PubMedID- 24313242 | Trauma exposure predicts alcohol, nicotine, and drug problems beyond the contribution of ptsd and depression in patients with cardiovascular disease: data from the heart and soul study. |
| PubMedID- 25667165 | depression leads to incident vascular disease: evidence for the relevance to primary care. |
| PubMedID- 24931717 | Cardiovascular disease risk factors associated with depression among korean adults with coronary artery disease and cerebrovascular disease. |
| PubMedID- 20153471 | It is also possible that the underlying pathology linking depression with cardiovascular disease (cvd) is specific to the coronary vessels. |
| PubMedID- 23381649 | Of particular note are the high rates of premature death due to cardiovascular disease in persons with depression and the prevalence of metabolic syndrome in those receiving treatments for major mood disorders. |
| PubMedID- 23672522 | Generally, more specific states (for example, depression in association with late-life vascular disease; first episode psychosis; cannabis-associated recurrence of psychosis; depressive episode following previous manic episode) provide a better fit with known risk factors, actual pathophysiology or known illness course and may be much more useful in research and some fields of clinical practice [83]. |
| PubMedID- 21118498 | The association between vascular disease with depression, apathy, anxiety and irritability remains although strength is reduced. |
| PubMedID- 25439033 | Adjusted odds ratios for depression rose monotonically with number of cardiovascular disease (cvd) risk factor from 1.46 (95% ci, 1.18-1.75) for those with one risk factors to 4.36 (95% ci, 2.47-7.70) for those with five risk factors. |
| PubMedID- 24307378 | Nevertheless, depression in patients with cardiovascular disease is not only associated with clinical outcomes, but also with adherence and poorer health status and impairments to quality of life independent of disease severity [26]. |
| PubMedID- 24175177 | Platelets and depression in cardiovascular disease: a brief review of the current literature. |
| PubMedID- 20690128 | Cardiovascular disease and death associated with depression and antidepressants in the melbourne longitudinal studies on healthy ageing (melsha). |
| PubMedID- 24058602 | There is also evidence to suggest that routine depression screening in patients with cardiovascular disease may not lead to improvement in clinical outcomes [15,16]. |
| PubMedID- 25653245 | Glucose levels may predict depression in patients with cardiovascular diseases. |
| PubMedID- 22849956 | Trial evidence has not suggested that treating depression decreases mortality in patients with existing cardiovascular disease,515253 but evidence from the current study of the increased risk associated with even low levels of psychological distress in the general population suggests that the overall picture may be more complex. |
| PubMedID- 25044493 | Aims: symptoms of anxiety and depression often co-exist with cardiovascular disease, yet little is known about the prospective risk for heart failure (hf) in people with symptoms of depression and anxiety. |
| PubMedID- 25633682 | Neuroimaging studies suggest that atrophy of temporal or frontal structures, white matter lesions in frontal lobe or subcortical systems, reduced activity in dorsolateral frontal cortex, or small vessel cerebrovascular disease may be associated with depression in ad. |
| PubMedID- 22783296 | This observation contributes to the hypothesis that depression is linked with cardiovascular disease through platelet dysregulation. |
| PubMedID- 23631737 | For example, depression is significantly associated with cardiovascular disease, diabetes, obesity, asthma, epilepsy, and cancer and with health risk behaviors such as alcohol abuse [8-11]. |
| PubMedID- 23611535 | Persistence of subsyndromal residual symptoms after remission of major depression in patients without cardiovascular disease may condition maintenance of elevated platelet factor 4 and beta-thromboglobulin plasma levels. |
| PubMedID- 22260713 | depression is associated with cardiovascular disease. |
| PubMedID- 25910599 | depression in cardiovascular disease: from awareness to action. |
| PubMedID- 22216404 | In the women's health initiative, women with depression but no history of cardiovascular disease were not at increased risk of stroke, whereas those with a history of prior cardiovascular disease were at 45% increased risk of stroke [28]. |
| PubMedID- 24715877 | This stress paradigm has recently been applied to study the shared pathophysiology that links stress-related psychological disorders such as anxiety and depression with cardiovascular disease (carnevali et al., 2012b, 2013b; wood et al., 2012; sevoz-couche et al., 2013). |
| PubMedID- 20859545 | Absolute contraindications to β-blockers are severe or advanced bradycardia, conduction system disease (sinus node dysfunction and/or high-grade av block), asthma, peripheral vascular disease (pad) with rest ischemia, depression, and overt heart failure (hf). |
| PubMedID- 21904685 | Many affected individuals suffer from comorbid depression, an increased risk of cardiovascular disease, and excessive nicotine, alcohol, and cannabis use. |
Page: 1 2